Workflow
青岛蔚蓝生物股份有限公司2025年第三季度报告
Shang Hai Zheng Quan Bao·2025-10-28 21:46

Core Points - The company has announced the cancellation of its supervisory board and the revision of its articles of association, with the responsibilities of the supervisory board being transferred to the audit committee of the board of directors [30][31]. - The company held its 21st meeting of the fifth board of directors on October 28, 2025, where several important resolutions were passed, including the approval of the third quarter report for 2025 [9][10]. - The company plans to hold its first extraordinary general meeting of 2025 on November 13, 2025, to discuss the cancellation of the supervisory board and other governance matters [27]. Financial Data - The third quarter financial report for 2025 has been prepared but is not audited [3][4]. - The report includes significant non-recurring gains and losses, although specific amounts are not detailed in the provided documents [4]. Governance Changes - The company will no longer have a supervisory board, and its functions will be assumed by the audit committee, with necessary amendments made to the articles of association [31]. - Various governance documents and rules are being revised or established to enhance the company's operational standards, including rules for shareholder meetings and board meetings [16][20][21]. Shareholder Information - The company has confirmed that the resolutions passed during the board meeting received unanimous support, with all five directors voting in favor [12][15][28].